FDA Drug Recalls
778 recalls, newest first
Class II · Moderate risk Ongoing Sep 12, 2025
Reason Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with…
Class II · Moderate risk Ongoing Sep 12, 2025
Reason Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with…
Class II · Moderate risk Ongoing Sep 12, 2025
Reason Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with…
Class II · Moderate risk Ongoing Sep 12, 2025
Reason Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with…
Class II · Moderate risk Ongoing Sep 12, 2025
Reason Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with…
Class II · Moderate risk Ongoing Sep 12, 2025
Reason Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with…
Class III · Low risk Ongoing Sep 12, 2025
Reason Labeling: Not Elsewhere Classified
Class III · Low risk Ongoing Sep 12, 2025
Reason Tablet/Capsules Imprinted with Wrong ID
Class III · Low risk Ongoing Sep 12, 2025
Reason Tablet/Capsules Imprinted with Wrong ID
Class II · Moderate risk Ongoing Sep 12, 2025
Reason CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit
Class II · Moderate risk Ongoing Sep 12, 2025
Reason CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit
Class II · Moderate risk Ongoing Sep 12, 2025
Reason CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit
Class II · Moderate risk Ongoing Sep 12, 2025
Reason CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit
Class II · Moderate risk Ongoing Sep 12, 2025
Reason CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit
Class II · Moderate risk Ongoing Sep 5, 2025
Reason Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns
Class II · Moderate risk Ongoing Sep 5, 2025
Reason Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns
Class II · Moderate risk Ongoing Sep 5, 2025
Reason cGMP deviations: Temperature excursion during transportation.
Class III · Low risk Ongoing Sep 5, 2025
Reason Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
Class II · Moderate risk Ongoing Sep 4, 2025
Reason Failed Impurity/Degradation Specifications
Class II · Moderate risk Ongoing Sep 4, 2025
Reason Failed Impurity/Degradation Specifications
Class II · Moderate risk Ongoing Sep 3, 2025
Reason Failed Dissolution Specifications-Out of Specification (OOS) observation for sulphate in Sodium Tartrate Dihydrate used for the production of…
Class II · Moderate risk Ongoing Sep 3, 2025
Reason CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
Class II · Moderate risk Ongoing Sep 3, 2025
Reason CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
Class II · Moderate risk Ongoing Sep 3, 2025
Reason CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
Class II · Moderate risk Ongoing Sep 3, 2025
Reason CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit